In the world, 25% of people have non-alcoholic fatty liver disease (NAFLD). A 63% raise in NASH cases is expected in 2030, compared to 2015.
NASH refers to the most advanced stage of non-alcoholic fatty liver disease, and involves a combination of fat accumulation, inflammation and lesions in the hepatocyte cells. In particular, these alterations can lead to cirrhosis or liver cancer. Associated with sedentary lifestyles and poor eating habits, this epidemic has been silently spreading across developed countries. Prevention and treatment of risk factors are the only “therapeutic” solutions currently available. TOTUM•448